STOCK TITAN
  1. Home
  2. Sec-filings
  3. DVAX
  4. [SCHEDULE 13G/A] Dynavax Technologies Corporation SEC Filing

[SCHEDULE 13G/A] Dynavax Technologies Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock DVAX logo
Dynavax Technolo

NASDAQ:DVAX

DVAX Rankings

#2519 Ranked by Market Cap
N/A Ranked by Dividends

DVAX Latest News

Aug 27, 2025
Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
Aug 21, 2025
Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
Aug 7, 2025
Dynavax Reports Second Quarter 2025 Financial Results
Jul 29, 2025
Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
Jun 11, 2025
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

DVAX Latest SEC Filings

Aug 25, 2025
[SCHEDULE 13G/A] Dynavax Technologies Corporation SEC Filing
Aug 25, 2025
[Form 4] Dynavax Technologies Corporation Insider Trading Activity
Aug 22, 2025
[Form 4] Dynavax Technologies Corporation Insider Trading Activity
Aug 21, 2025
[8-K] Dynavax Technologies Corporation Reports Material Event
Aug 7, 2025
[8-K] Dynavax Technologies Corporation Reports Material Event

DVAX Stock Data

1.20B
116.51M
0.6%
99.68%
12.36%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
EMERYVILLE